A Phase I/II Single-Centre Double-Blinded Randomized Study of the Safety and Tolerability of TMC120 Vaginal Microbicide Gel Vs. HEC-Based Universal Placebo Gel in Healthy HIV-Negative Women.

Trial Profile

A Phase I/II Single-Centre Double-Blinded Randomized Study of the Safety and Tolerability of TMC120 Vaginal Microbicide Gel Vs. HEC-Based Universal Placebo Gel in Healthy HIV-Negative Women.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Dapivirine (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Sponsors International Partnership for Microbicides
  • Most Recent Events

    • 31 Jul 2009 Results have been reported in AIDS.
    • 21 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top